glp-1 industry Market Size, Share Who are the leading innovators
Description
These consultations allow monitoring of: Glycaemic control through HbA1c measurements (usually every 36 months) Weight changes and body composition Tolerability and adverse effects , particularly gastrointestinal symptoms Blood pressure and heart rate Renal function tests NICE recommends (NG28) that GLP-1 therapy should be continued only if there is demonstrable benefittypically defined as an HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months for diabetes indications
It is important to note that these energy improvements typically develop gradually over weeks to months as metabolic changes take effect, rather than immediately upon starting treatment
doi:10.1177/17455057251384412
In that way, it balances the actions of the GLP-1 pathway, ensuring blood sugar levels dont drop or spike above a certain threshold
Actionable Tip: Aim to drink at least 64 ounces of water per day
The fact that we didnt should tell you something
